Paloma Partners Management CO Heron Therapeutics, Inc. Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$17.42 - $26.61 $195,609 - $298,803
-11,229 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$16.36 - $21.39 $183,706 - $240,188
11,229 New
11,229 $208,000
Q1 2018

May 15, 2018
SELL
$18.43 - $28.8 $235,332 - $367,747
-12,769 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$14.8 - $18.85 $188,981 - $240,695
12,769
12,769 $231,000

Others Institutions Holding HRTX

# of Institutions
180
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email